The stem cell research in the USA is likely to have a major boost when a grant of $24 million was awarded by The California Institute for Regenerative Medicine to stem cell research in the state. Of the money, $23 million will be donated to the research into the derivation and propagation of new lines of pluripotent human stem cells. Such kind of research is important as it can play a major role in treating major diseases and serious injuries among human being.
The five year old child is left with the only option of death. And now the family is waiting for her death helplessly as they have nothing to do. Reason? The girl was denied flight to China for stem cell treatment. The sick little American girl whose family has raised $70,000 for potentially life-saving treatments in China was crushed last week when both Air Canada and Air China denied her permission to board a connecting flight from Vancouver International Airport to Beijing. Hailey Goranflo of Shepherdsville, was suffering from a rare, genetic brain disorder Batten’s disease.
The stem cell research is likely to enter a new stage when the Stemagen Corporation, based in La Jolla, California, claims that it used cloning technology to make five human embryos. This means that hope is on the horizon that they will be able to make matched stem cells for patients.
In an attempt to help the stem cell scientists worldwide, the BioTime has decided to launch a complex database this afternoon. It is expected be a breakthrough stem-cell tool that will put this small company on the world stage. This database, will be accessed through the Web site www.embryome.com. It will serve as a vehicle to allow more than 5,000 experts worldwide to channel their knowledge of how complex cell types can be formed and how they can be differentiated from one to another. The creation is the backbone of the International Embryome Initiative, which is part of Embryome Sciences Inc., a wholly-owned subsidiary of BioTime.
The stem cell therapy can soon take the place of cosmetic solutions like Silicon breast implants and Botox. In the new technique doctors can make plastic-surgery miracles using only a patient’s own stem cells.Traditionally, plastic and reconstructive surgery has relied heavily on fillers. Bags full of saline or silicone are used to plump up breasts. Chunks of fat are taken from one area of the body and grafted into another. The techniques, though successful and popular, can lead to various problems.
HepaLife Technologies, Inc., announces the development of two new derivative cell lines which can be used for the treatment of human liver failure. This stem cell lines will be used in Hepalife’s first -of-its-kind Bio artificial liver device which is currently under development phase.
California Stem Cell Inc.is all set to hit the headlines very soon. This tiny start up company in Irvine is likely to be the first company of the world to test the embryonic stem cell treatment in humans. The company is eyeing for an FDA approval next year. And for the primary stage, they target mainly two diseases, ALS, or Lou Gehrig’s Disease and SMA. Both of them are degenerative nerve diseases that effect the adult and the new born respectively.
Scientists at the Burnham Institute for Medical Research have been successful to convert genetically programmed embryonic stem cells into nerve cells when transplanted into the brain. The study is expected to be the next big step in treatments for stroke, Alzheimer’s, Parkinson’s and other neurological conditions. The study, published in the Journal of Neuroscience showed that mice afflicted by stroke showed tangible therapeutic improvement following transplantation of these cells.
In a major breakthrough in stem cell research, a veterinarian in Memphis has successfully applied the cutting edge stem cell therapy to treat the hip dysplasia in German shepherd, Blue. Kathy Mitchener who did the treatment for the dog has taken only two days. Mitchener recently became certified to perform the stem-cell treatment, pioneered by the company Vet-Stem based in San Diego.
Assemblyman Neil M. Cohen today has announced “New Jersey Stem Cell Research Assistance Act” today to help the research opportunity in Garden State. The act will encourage venture capitalists to invest in research funding. The bill would allow investors to contribute up to $500 million over five years to fund stem cell research in New Jersey. Cohen,a prominent supporter of stem cell research permitted stem cell research in New Jersey as well as the laws creating umbilical cord blood collection centers and world-class stem cell research facilities in the state.